A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Inadequately Controlled, Severe Asthma
A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MEDI9929 in Adult Subjects With Inadequately Controlled, Severe Asthma
The primary objective of the study is to evaluate the effect of 3 dose levels of MEDI9929 (AMG 157) on asthma exacerbations in adult subjects with inadequately controlled, severe asthma.
Inclusion Criteria:
Exclusion Criteria:
Farkasgyepü, 8582, Hungary
Fujisawa-shi, 251-8550, Japan
Kiyose-shi, 204-8585, Japan
Kurume-shi, 830-0011, Japan
Ora-gun, 370-0615, Japan
Sagamihara-shi, 228-0815, Japan
Saitama-Ken, 338-8553, Japan
Taito-ku, 111-0051, Japan
Toshima-ku, 171-0014, Japan
Yokkaichi-shi, 510-8567, Japan
Suprunivka Vil., Poltava Regio, 36028, Ukraine